Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice

European Journal of Clinical Investigation

Volumn 30, Issue 6, 2000, Pages 505-510

  Oldenburg, B ^b   Van Berge Henegouwen, G P ^c   Rennick, D ^a   Van Asbeck, B S ^c   Koningsberger, J C ^c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NONE

Author keywords

IL 10 knock out mouse; Iron; Pro inflammatory cytokines

Indexed keywords

CYTOKINE; HYDROXYL RADICAL; INTERLEUKIN 10; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DISEASE ACTIVITY; ENTERITIS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TIME;

ANIMALS; COLON; ENEMA; FERROUS COMPOUNDS; HEMOGLOBINS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-1; INTERLEUKIN-10; INTESTINAL MUCOSA; IRON, DIETARY; LEUKOCYTE COUNT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; ORGAN CULTURE TECHNIQUES; PLATELET COUNT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034074688     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00650.x     Document Type: Article

References (18)

1. 1 Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994;344:859-61.
2. 2 Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB, Bulkley GB. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease. Cause, consequence, or epiphenomenon? Pharmacol Ther 1992;53: 375-408.
3. 3 Conner EM, Brand SJ, Davis JM, Kang DY, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. Inflammatory Bowel Diseases 1996;2:133-47.
4. 4 Klebanoff SJ. Oxygen Metabolites from Phagocytes In: Gallin JI, Goldstein IM, Snyderman R, editors. New York:Raven press;1992.p.541-88.
5. 5 Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J et al. Recombinant erythropoietin for the treatment of anaemia of inflammatory bowel disease. N Engl J Med 1996;334:619-23.
6. 6 Kühn R, Lohler J, Rennick D, Rajewsky K, Müller W. Interleukin 10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
7. 7 Berg D, Leach M, Kühn R, Rajewsky K, Müller W, Rennick D. Inflammatory bowel disease in IL-10 deficient mice. (Abstract) FASEB J 1994;8:A208.
8. + Th1-like responses. J Clin Invest 1996;98: 1010-20.
9. 9 Kadiiska MB, Burkitt MJ, Xiang Q-H, Mason RP. Iron supplementation generates hydroxyl radical in vivo. J Clin Invest 1995;96:1653-7.
10. 10 Simmonds NJ, Allen RE, Stevens TRJ et al. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterol 1992;103: 186-96.
11. 11 Carrier J, Aghdassi E, Cullen J, Allard JP. Effect of dietary iron supplementation on intestinal inflammation and oxidative stress in rats with induced colitis. Gastroenterol 1999;116:A866.
12. 12 Aghdassi E, Carrier J, Cullen J, Allard JP. Iron load and its effects on oxidative stress and inflammation in rats with induced colitis. Gastroenterol 1999;116:A853.
13. 13 Lloyd KN, Williams P. Reactions to total dose infusion of iron dextran in rheumatoid arthritis. Br Med J 1970;ii:323-5.
14. 14 Blake D, Bacon PA. The importance of iron in rheumatoid arthritis. Lancet 623 1982.
15. 15 Schreck R, Rieber P, Bauerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NfκB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
16. 16 Kopp EB, Ghosh S. NfκB and Rel proteins in innate immunity. Adv Immunol 1995;58:1-27.
17. 17 Barnes PJ, Karin M. Nuclear factor κB: a pivotal transcription factor in chronic inflammatory diseases. NEJM 1997;336:1066-71.
18. 18 Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor κB in inflammatory bowel disease. Gut 1998;42: 477-84.